Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs

器官移植后，接受者需要持续服用药物来阻止免疫系统排斥新器官。这种免疫抑制药物治疗对移植的长期成功至关重要。然而，由于管理不善的免疫抑制，太多的人正在失去他们的移植，或者正在经历药物毒性或感染。该项目旨在准确确定在澳大利亚移植人群中使用新免疫抑制药物的最佳方式。

After organ transplantation, recipients need to take medicines continually to stop their immune system from rejecting their new organ. This treatment with immunosuppressant drugs is vital for long-term success of their graft. However, too many people are losing their transplant or are experiencing drug toxicity or infection due to poorly managed immunosuppression. The project aims to accurately define the best way to dose newer immunosuppressant drugs in Australian transplant populations.